A randomised, double-blind, active-controlled phase 2 trial to evaluate a novel selective and reversible intravenous and oral P2Y12 inhibitor elinogrel versus clopidogrel in patients undergoing nonurgent percutaneous coronary intervention: the INNOVATE-PCI trial - Welsh, RC; Rao, SV; Zeymer, U (Circ Cardiovasc Interv, 2012)
et al.